Work

Dehydroepiandrosterone (DHEA) in metastatic castration-resistant prostate cancer (mCRPC): Preliminary results from the SU2C/PCF/AACR West Coast Dream Team (WCDT).

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.e16598

Authors: Won Kim, Charles J. Ryan, Li Zhang, Jack Youngren, John Wilton, Joshi J. Alumkal, Tomasz M. Beer, Robert Baertsch, Josh Stuart, Kim N. Chi, Martin Gleave, Matthew Rettig, Robert Evan Reiter, Primo Lara, Christopher P. Evans, Eric Jay Small

Institutions: University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, Roswell Park Comprehensive Cancer Center, Oregon Health & Science University, OHSU Knight Cancer Institute, University of California, Santa Cruz, BC Cancer Agency, University of British Columbia, Vancouver Prostate Centre, University of California, Los Angeles, UCLA Jonsson Comprehensive Cancer Center, University of California, Davis

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2493710408

Cites:

Cited by: 2

Related to: 10